The George Institute For Global Health
Global
United Kingdom
India
China
Australia

Home

Found 358 results
Filters: Author is Anushka Patel
2017
Maulik PK, Kallakuri S, Devarapalli S, Vadlamani VKrishna, Jha V, Patel A. Increasing use of mental health services in remote areas using mobile technology: a pre-post evaluation of the SMART Mental Health project in rural India. J Glob Health. 2017;7(1):010408. doi:10.7189/jogh.07.010408.
Patel A. Innovation in Healthcare (keynote plenary). In: SPHERE 2017 International Symposium. SPHERE 2017 International Symposium. Sydney, Australia; 2017.
Tian M, Zhang J, Luo R, et al. mHealth Interventions for Health System Strengthening in China: A Systematic Review. JMIR Mhealth Uhealth. 2017;5(3):e32. doi:10.2196/mhealth.6889.
Peng Y, Du X, Rogers KD, Wu Y, Gao R, Patel A. Predicting In-Hospital Mortality in Patients With Acute Coronary Syndrome in China. Am J Cardiol. 2017;120(7):1077-1083. doi:10.1016/j.amjcard.2017.06.044.
Tewari A, Kallakuri S, Devarapalli S, Jha V, Patel A, Maulik PK. Process evaluation of the systematic medical appraisal, referral and treatment (SMART) mental health project in rural India. BMC Psychiatry. 2017;17(1):385. doi:10.1186/s12888-017-1525-6.
Chow CK, Thakkar J, Bennett A, et al. Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review. Lancet. 2017;389(10073):1035-1042. doi:10.1016/S0140-6736(17)30260-X.
Patel A, Billot L. Reality and Truth: Balancing the Hope and the Hype of Real-World Evidence. Circulation. 2017;136(3):260-262. doi:10.1161/CIRCULATIONAHA.117.029233.
Patel A, Pieper K, Myburgh J, et al. Reanalysis of the Crystalloid versus Hydroxyethyl Starch Trial (CHEST). N Engl J Med. 2017;377(3):298-300. doi:10.1056/NEJMc1703337.
Patel A. Redefining women’s health in the era of the Sustainable Development Goals (plenary). In: National Heart Foundation Women and Heart Disease Forum. National Heart Foundation Women and Heart Disease Forum. Sydney, Australia; 2017.
Chalasani S, Peiris DP, Usherwood T, et al. Reducing cardiovascular disease risk in diabetes: a randomised controlled trial of a quality improvement initiative. Med J Aust. 2017;206(10):436-441.
Xie G, Sun Y, Myint PKyaw, et al. Six-month adherence to Statin use and subsequent risk of major adverse cardiovascular events (MACE) in patients discharged with acute coronary syndromes. Lipids Health Dis. 2017;16(1):155. doi:10.1186/s12944-017-0544-0.
Patel A. Technology and Health (panel). In: IMPACT7. IMPACT7. Melbourne, Australia; 2017.
Du X, Patel A, Li X, Wu Y, Turnbull F, Gao R. Treatment and outcomes of acute coronary syndromes in women: An analysis of a multicenter quality improvement Chinese study. Int J Cardiol. 2017. doi:10.1016/j.ijcard.2017.03.090.
Atkins E, Du X, Wu Y, Gao R, Patel A, Chow CK. Use of cardiovascular prevention treatments after acute coronary syndrome in China and associated factors. Int J Cardiol. 2017. doi:10.1016/j.ijcard.2017.03.057.
Redfern J, Hyun K, Atkins E, et al. Utilisation of Medicare-funded schemes for people with cardiovascular disease. Aust J Prim Health. 2017;23(5):482-488. doi:10.1071/PY16166.
Patel A. What is the optimal target for glucose control in patients with increased cardiovascular risk [Plenary]. In: Bridging the gap between guidelines and practice. Bridging the gap between guidelines and practice. Manila, Philippines; 2017.
Patel A. What’s happened to the polypill? (symposium). In: Cardiac Society of Australia and New Zealand Annual Scientific Meeting 2017. Cardiac Society of Australia and New Zealand Annual Scientific Meeting 2017. Perth, Australia; 2017.
2016
Mohammedi K, Woodward M, Zoungas S, et al. Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes. Diabetes Care. 2016.
Hayek A, Joshi R, Usherwood T, et al. An integrated general practice and pharmacy-based intervention to promote the use of appropriate preventive medications among individuals at high cardiovascular disease risk: protocol for a cluster randomized controlled trial. Implement Sci. 2016;11(1):129. doi:10.1186/s13012-016-0488-1.
Patel A. An update on cardiovascular polypills (plenary). In: 27th Great Wall International Congress of Cardiology. 27th Great Wall International Congress of Cardiology. Beijing, China; 2016.
Patel A. Choosing the right study design (symposium). In: 27th Great Wall International Congress of Cardiology. 27th Great Wall International Congress of Cardiology. Beijing, China; 2016.
Gupta Y, Kapoor D, Desai A, et al. Conversion of gestational diabetes mellitus to future Type 2 diabetes mellitus and the predictive value of HbA in an Indian cohort. Diabetic Medicine. 2016.
Laba TL, Patel A, Jan S. Creating a new investment pool for innovative health systems research. Australian Health Review. 2016.
Selak V, Bullen C, Stepien S, et al. Do polypills lead to neglect of lifestyle risk factors? Findings from an individual participant data meta-analysis among 3140 patients at high risk of cardiovascular disease. European Journal of Preventive Cardiology. 2016;pii: 2047487316638216.
Hyun K, Redfern J, Peiris D, et al. Gender Inequalities in Cardiovascular Disease Prevention and Management in Australian Primary Health Care: Results from the TORPEDO Study. Heart, Lung and Circulation. 2016;25:S319.

Pages